NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 332 filers reported holding NATERA INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,954,920 | -13.9% | 383,162 | -5.3% | 0.00% | 0.0% |
Q2 2023 | $19,690,683 | -9.7% | 404,659 | +3.0% | 0.00% | -20.0% |
Q1 2023 | $21,803,315 | +39.3% | 392,711 | +0.8% | 0.01% | +25.0% |
Q4 2022 | $15,652,643 | +1.3% | 389,660 | +10.5% | 0.00% | 0.0% |
Q3 2022 | $15,456,000 | +35.2% | 352,742 | +9.4% | 0.00% | +33.3% |
Q2 2022 | $11,431,000 | -65.8% | 322,539 | -60.7% | 0.00% | -50.0% |
Q1 2022 | $33,399,000 | -53.5% | 820,974 | +6.7% | 0.01% | -53.8% |
Q4 2021 | $71,833,000 | -18.0% | 769,183 | -2.1% | 0.01% | -23.5% |
Q3 2021 | $87,575,000 | -4.2% | 785,852 | -2.4% | 0.02% | -5.6% |
Q2 2021 | $91,373,000 | +5.1% | 804,838 | -6.0% | 0.02% | 0.0% |
Q1 2021 | $86,973,000 | +7.0% | 856,548 | +4.9% | 0.02% | 0.0% |
Q4 2020 | $81,282,000 | +43.4% | 816,749 | +4.1% | 0.02% | +28.6% |
Q3 2020 | $56,694,000 | +49.6% | 784,829 | +3.3% | 0.01% | +40.0% |
Q2 2020 | $37,891,000 | +83.3% | 759,975 | +9.8% | 0.01% | +42.9% |
Q1 2020 | $20,676,000 | -25.4% | 692,415 | -15.8% | 0.01% | 0.0% |
Q4 2019 | $27,720,000 | -2.6% | 822,767 | -5.2% | 0.01% | -12.5% |
Q3 2019 | $28,461,000 | +156.1% | 867,686 | +115.3% | 0.01% | +166.7% |
Q2 2019 | $11,114,000 | +51.9% | 402,986 | +13.6% | 0.00% | +50.0% |
Q1 2019 | $7,317,000 | +37.7% | 354,839 | -6.7% | 0.00% | 0.0% |
Q4 2018 | $5,312,000 | -65.1% | 380,490 | -40.1% | 0.00% | -50.0% |
Q3 2018 | $15,200,000 | +24.1% | 634,893 | -2.5% | 0.00% | +33.3% |
Q2 2018 | $12,251,000 | +123.0% | 650,968 | +9.8% | 0.00% | +50.0% |
Q1 2018 | $5,494,000 | +15.3% | 592,744 | +11.8% | 0.00% | +100.0% |
Q4 2017 | $4,765,000 | -33.3% | 530,093 | -4.3% | 0.00% | -50.0% |
Q3 2017 | $7,141,000 | +3.6% | 554,033 | -12.7% | 0.00% | 0.0% |
Q2 2017 | $6,893,000 | +24.3% | 634,743 | +1.5% | 0.00% | 0.0% |
Q1 2017 | $5,547,000 | -26.3% | 625,520 | -2.7% | 0.00% | 0.0% |
Q4 2016 | $7,527,000 | +6.3% | 642,768 | +0.9% | 0.00% | 0.0% |
Q3 2016 | $7,078,000 | +22.0% | 637,082 | +32.5% | 0.00% | 0.0% |
Q2 2016 | $5,802,000 | +1288.0% | 480,900 | +994.7% | 0.00% | – |
Q1 2016 | $418,000 | +31.9% | 43,930 | +49.6% | 0.00% | – |
Q4 2015 | $317,000 | +19.6% | 29,363 | +20.0% | 0.00% | – |
Q3 2015 | $265,000 | – | 24,461 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 3,100,560 | $314,831,000 | 18.93% |
Blue Water Life Science Advisors, LP | 328,836 | $33,390,000 | 16.31% |
Foresite Capital Management III, LLC | 127,305 | $12,927,000 | 11.35% |
HWG Holdings LP | 148,794 | $15,109,000 | 7.53% |
Eagle Health Investments LP | 168,394 | $17,099,000 | 6.71% |
Lagoda Investment Management, L.P. | 103,325 | $10,492,000 | 5.24% |
Ally Bridge Group (NY) LLC | 218,000 | $22,136,000 | 4.24% |
PERKINS CAPITAL MANAGEMENT INC | 63,950 | $6,493,000 | 3.76% |
BRIDGER MANAGEMENT, LLC | 388,620 | $39,460,000 | 3.68% |
Hudson Executive Capital LP | 527,086 | $53,520,000 | 3.32% |